Effects of creatine treatment on survival and differentiation of GABA‐ergic neurons in cultured striatal tissue
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder, characterized by a prominent loss of GABA‐ergic medium‐sized spiny neurons in the caudate putamen. There is evidence that impaired energy metabolism contributes to neuronal death in HD. Creatine is an endogenous substrate for creatine kinases and thereby supports cellular ATP levels. This study investigated the effects of creatine supplementation (5 m m) on cell survival and neuronal differentiation in striatal cultures. Chronic creatine treatment resulted in significant increased densities of GABA‐immunoreactive (‐ir) neurons, although total neuronal cell number and general viability were not affected. Similar effects were seen after short‐term treatment, suggesting that creatine acted as a differentiation factor. Inhibitors of transcription or translation did not abolish the creatine‐mediated effects, nor did omission of extracellular calcium, whereas inhibition of mitogen‐activated protein kinase and phosphatidylinositol‐3‐kinase significantly attenuated the creatine induced increase in GABA‐ir cell densities. Creatine exhibited significant neuroprotection against toxicity instigated either by glucose‐ and serum deprivation or addition of 3‐nitropropionic acid. In sum, the neuroprotective properties in combination with promotion of neuronal differentiation suggest that creatine has potential as a therapeutic drug in the treatment of neurodegenerative diseases, like HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758 · cited 2×
“Recently, evidence has grown that impaired energy metabolism due to reduced mitochondrial complex-II and complex-III activity contributes to neuronal death during the course of the disorder (Gu et al. 1996; Calabresi et al. 2001).”
BackgroundNeuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405 · cited 1×
“(2005) 95, 33–45 33 also show a reduced phosphocreatine/Pi ratio in skeletal muscle (Koroshetz et al. 1997).”
BackgroundBrewer, G. J., & Wallimann, T. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741968.x · Cited by 230
Self-citationDedeoglu, A., Kubilus, J. K., Yang, L., Ferrante, K. L., Hersch, S. M., Beal, M. F., & Ferrante, A. R. J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01706.x · Cited by 169 · cited 1×
“Protective effects of creatine treatment have been reported in the R6/2 transgenic mouse model of HD (Ferrante et al. 2000; Dedeoglu et al. 2003).”
Background
Cited by
Functions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Self-citationHuman neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain
Andres, R. H., Horie, N., Slikker, W., Keren-Gill, H., Zhan, K., Sun, G., Manley, N. C., Pereira, M. P., Sheikh, L. A., McMillan, E. L., et al. (2011) · Brain · doi:10.1093/brain/awr094 · Cited by 329
“2 (Coleman and Riesen, 1968).”
MethodSelf-citationMitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
In sickness and in health: the widespread application of creatine supplementation
Gualano, B., Roschel, H., Lancha, A. H., Brightbill, C. E., & Rawson, E. S. (2012) · Amino Acids · doi:10.1007/s00726-011-1132-7 · Cited by 172
Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
Prass, K., Royl, G., Lindauer, U., Freyer, D., Megow, D., Dirnagl, U., Stöckler-Ipsiroglu, G., Wallimann, T., & Priller, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600351 · Cited by 128
Self-citation
Metadata
- Authors
- Andres, R. H., Ducray, A. D., Huber, A. W., Pérez‐Bouza, A., Krebs, S. H., Schlattner, U., Seiler, R. W., Wallimann, T., & Widmer, H. R.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2005-08-25
- Volume
- 95
- Issue
- 1
- Pages
- 33-45
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1737744869
- Cited by
- 58
- References
- 5
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of creatine treatment on survival and differentiation of GABA‐ergic neurons in cultured striatal tissue. https://app.cochat.ai/papers/10.1111/j.1471-4159.2005.03337.x
- The paper
- Andres, R. H., Ducray, A. D., Huber, A. W., Pérez‐Bouza, A., Krebs, S. H., Schlattner, U., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005). Effects of creatine treatment on survival and differentiation of GABA‐ergic neurons in cultured striatal tissue. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2005.03337.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.